Allograft Clinical Trials

15 recruitingLast updated: May 21, 2026

There are 15 actively recruiting allograft clinical trials across 16 countries. Studies span Phase 3, Not Applicable, Phase 2, Phase 1, Phase 4. Top locations include Ottawa, Ontario, Canada, Toronto, Ontario, Canada, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Allograft Trials at a Glance

15 actively recruiting trials for allograft are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Ottawa, Toronto, and Chicago. Lead sponsors running allograft studies include Ottawa Heart Institute Research Corporation, Centre Hospitalier Universitaire de Nīmes, and Bristol-Myers Squibb.

Browse allograft trials by phase

About Allograft Clinical Trials

Looking for clinical trials for Allograft? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Allograft trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Allograft clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 2

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.

Bronchiolitis Obliterans SyndromeLung transplantationChronic lung allograft dysfunction
Steven Hays, MD30 enrolled1 locationNCT06018766
Recruiting
Phase 3

AERIAL Trial: Antiplatelet Therapy in Heart Transplantation

Heart TransplantCardiac Allograft Vasculopathy
Ottawa Heart Institute Research Corporation135 enrolled3 locationsNCT04770012
Recruiting
Not Applicable

MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation

Cardiac Allograft Vasculopathy
Ottawa Heart Institute Research Corporation576 enrolled5 locationsNCT06089486
Recruiting

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Acute Rejection (AR) of Transplanted KidneyChronic Allograft Nephropathy (CAN)Interstitial Fibrosis (IF)+1 more
Northwestern University1,000 enrolled1 locationNCT01531257
Recruiting
Phase 3

A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Renal Allograft Recipients
Bristol-Myers Squibb102 enrolled38 locationsNCT04877288
Recruiting
Not Applicable

Comparison of Two Types of Bone Grafts in Patients Who Need One of Their Front Teeth Removed and Replaced With an Implant

Ridge PreservationAllograftsExtraction, Tooth+1 more
University of Rochester50 enrolled1 locationNCT06722482
Recruiting

A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function With Non-contrast Functional Magnetic Resonance Imaging

Kidney TransplantRenal Allograft RecipientsRenal Allograft
Tongji Hospital1,000 enrolled3 locationsNCT07333495
Recruiting
Phase 1Phase 2

Chronic Lung Allograft Dysfunction MRI Study

Chronic Lung Allograft Dysfunction Lung MRI (CLAD)
Sean Fain100 enrolled1 locationNCT06406777
Recruiting

Physiologic Assessment of Microvascular Function in Heart Transplant Patients

Cardiac Allograft Vasculopathy
Samsung Medical Center200 enrolled1 locationNCT02798731
Recruiting
Phase 4

Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure

Graft RejectionGraft FailureRenal Failure Chronic+2 more
Hospital Universitari Vall d'Hebron Research Institute202 enrolled1 locationNCT06676696
Recruiting

Clinical Efficacy and Long-term Outcomes of ALLOgraft Versus Stented Biological Prosthesis for Primary TRIcuspid Valve Disease (ALLOTRI)

Tricuspid Valve DiseaseAllograftBioprosthesis
Chelyabinsk Regional Clinical Hospital56 enrolled1 locationNCT06591000
Recruiting

Microvascular Cardiac Allograft Vasculopathy Trial

Cardiac Allograft Vasculopathy
German Heart Institute50 enrolled1 locationNCT05826444
Recruiting

Immunological Reaction of the Recipient After Cold-stored Saphenous Venous Allograft (Bioprotec)

AllograftSaphenous VeinCold Temperature
Centre Hospitalier Universitaire de Nīmes50 enrolled1 locationNCT05096351
Recruiting
Phase 3

Budesonide versus prednisolone after liver transplantation: a phase 3, open label, non-inferiority randomised controlled trial

Allograft rejection
Austin Health100 enrolled1 locationACTRN12623000340639
Recruiting

A search of novel biomarkers in detecting early allograft dysfunction afterliving donor liver transplantation

early allograft dysfunctionliving donor liver transplantation
Chang Gung Memorial Hospital120 enrolled1 locationACTRN12619000386134